AnalytiChem will highlight its growing product portfolio of reference materials, specialised laboratory chemicals & reagents, consumables and sample preparation solutions at Analytica 2026.
Lonza and Genetix Biotherapeutics, a commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases, has announced the extension of their long-term commercial manufacturing agreement.
Sonia Schwantes, market and technical development director for NewAge Industries, looks at reducing Scope 1, Scope 2, and Scope 3 emissions innovatively.
ERWEKA highlights the TBH II Manual Tablet Hardness Tester, a benchmark solution for laboratories seeking comprehensive, manual tablet testing in a compact footprint.
Minister for Enterprise, Tourism and Employment Peter Burke, and representatives from IDA Ireland, visited Athlone Laboratories to consult with key figures on a vision for Ireland’s future in the domestic manufacturing of critical medicines.
Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility.
Testo Saveris is returning to LogiPharma in April to highlight how digital environmental monitoring can help the pharmaceutical industry make its supply chains more resilient, compliant and data-driven.
Antares Vision Group will offer live demonstrations of an integrated line providing automatic denesting, inspection and labelling for prefilled syringe production at INTERPHEX NYC, Booth 2821, 21-23rd April.
In February 2025, Future Biogas and AstraZeneca launched the UK’s first unsubsidised biomethane plant at Gonerby Moor. A year on, CEO Philipp Lukas explains why it proves green gas can scale without government support.
